Luteolin and cancer metastasis suppression: Focus on the role of epithelial to mesenchymal transition

Y Hussain, JH Cui, H Khan, M Aschner, GES Batiha… - Medical Oncology, 2021 - Springer
Epithelial to mesenchymal transition (EMT) is a physiological process that assumes a
primary role in the induction of cancer metastasis. This results in increased cell renewal, and …

Predictors for complete pathological response for stage II and III rectal cancer following neoadjuvant therapy-A systematic review and meta-analysis

Y Huang, D Lee, C Young - The American Journal of Surgery, 2020 - Elsevier
Background There has been an increasing interest in the complete pathological response
(pCR) in rectal cancers following neoadjuvant therapy. The aim of this study was to identify …

Pathological predictors of response to neoadjuvant treatment in rectal carcinoma

M Malekzadeh Moghani, S Alahyari, A Moradi… - Journal of …, 2021 - Springer
Purpose Neoadjuvant chemoradiotherapy has now become a standard treatment for rectal
cancer. Recently, attempts have been made to predict the response rate to this treatment to …

[PDF][PDF] Can we optimize CEA as a response marker in rectal cancer?

T Gago, P Caldeira, AC Cunha, P Campelo… - Rev Esp Enferm …, 2021 - online.reed.es
Background and aim: carcinoembryonic antigen (CEA) is a biomarker commonly used in
colorectal cancer. However, its prognostic value is still controversial. Recent studies …

[HTML][HTML] Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer

A Mehraj, AA Baba, B Khan, MA Khan… - Journal of Cancer …, 2022 - journals.lww.com
Background: Neoadjuvant chemoradiotherapy (NACRT) is an established treatment option
for locally advanced rectal cancer (LARC). Patients achieving pathological complete …

[PDF][PDF] Identification of Predictive Factors for Pathologic Complete Response in Rectal Cancer Patients Undergoing Neoadjuvant Treatment: A Retrospective Study

MT Georgescu, A Diaconu, I Iordan… - Chirurgia (Bucharest …, 2023 - revistachirurgia.ro
Introducere: Cancerul colorectal este o afecţiune severă, cu cancerul rectal reprezentând
treizeci la sută din toate cazurile. Pentru pacienţii diagnosticaţi cu cancer rectal …

Neoadjuvant chemotherapy and concomitant boost radiotherapy in the treatment of locally advanced rectal cancer

EA Abdallah, R Omar, SRA Aziz… - Journal of Cancer …, 2021 - scholar.sdpublishers.info
Aims: This study aimed to examine the efficacy and toxicities of concomitant boost three-
dimensional conformal radiotherapy along with multidrug chemotherapy (capecitabine and …

[PDF][PDF] Development of a 3D biomimetic in vitro platform to study EV cargo in rectal cancer radio-response

M da Cruz Ribeiro - 2022 - repositorio-aberto.up.pt
Durante o último ano, comecei a “trabalhar”. Deixando o panorama letivo, tive de ganhar
capacidade de trabalho, sentido de responsabilidade, autonomia e resiliência mental para …

Incidence of Pathological Complete Response after Neoadjuvant Treatment in Current Vajira Hospital Rectal Cancer Practice

P Chandrachamnong… - Srinagarind Medical …, 2022 - li01.tci-thaijo.org
Abstract Background and Objective: Colorectal cancer is the third most common cancer
worldwide. The current standard treatment for locally advanced rectal cancer is neoadjuvant …

[PDF][PDF] Mona Malekzadeh Moghani, Sam

AM Alahyari, M Nasiri - researchgate.net
Purpose Neoadjuvant chemoradiotherapy has now become a standard treatment for rectal
cancer. Recently, attempts have been made to predict the response rate to this treatment to …